EnhancerAtlas 2.0: an updated resource with typical enhancer annotation in 600 tissue/cell types across nine species

TagContent
EnhancerAtlas ID
HS139-21689 
Organism
Homo sapiens 
Tissue/cell
Myotube 
Coordinate
chr16:81785630-81786660 
TF binding sites/motifs
Number: 2             
TFJASPAR IDCoordinateMotif SequenceStrand-Log10(p-value)
SPI1MA0080.4chr16:81786030-81786044CACTTCCTCTTTTT-7.38
SPICMA0687.1chr16:81786030-81786044CACTTCCTCTTTTT-6.4
Number of super-enhancer constituents: 2             
IDCoordinateTissue/cell
SE_50750chr16:81785504-81786940Sigmoid_Colon
SE_59356chr16:81748879-81787025Ly3
Diseases: AD,Huntington,Obesity,Parkinson,Prostate cancer,Schizophrenia and Sleep disorder
Number of disease enhancers: 1             
ChromosomeStartEnd
chr168178597681786155
Number: 1             
IDChromosomeStartEnd
GH16I081751chr168178535581786885
Enhancer Sequence
AATAAATATA AAAAAAATAT AATATATGTA TATAATATAT ATAAAAGAGC TAGGATTTGA 60
ACCTGCAACT CTTCACTGTG ATGTAGGCCC CGTCTATCAC GTATGAACTA TGAGCCTGCT 120
GAGTGCTGGG TGCTGAGCTG GGAGCTCCCA CTGTTCCCCA ACACTGCGTC TCAGAGTTCC 180
CTGATGCTGG AAGCCTGGAG GCCCTCACAA TTCTAGGGTG TTTTTAGAAT ATCATTGTGG 240
GGTGAAAGCA GGTTCCAGCT TCCCCAGGTG GAAGGTTCCA AGAAGCACCC GGCCAGCTCT 300
GAGAAGTACC CGGCCAGCTC CTCCACTCTG CCTGACAGGG AGGGGACTGT GAGGGTTGGG 360
ACACGTCCTC TTTTAAGGCT CTCTCTTGCT GGCTTCTGAC CACTTCCTCT TTTTCCTGGG 420
GTGGAGGCGG CTGGCCGTGG CAGCACTAAT AGCAGCTGGG GGCGGAGCAG GCCTCCAAAA 480
ACCCTCCCGG AGTGGCTCAG CCCCTCGGCT GAGGGCAGGA GAGCAAGAGT CCACTTCAGC 540
TTCCATCTGA GGTCTCTGTG AGCCCCCAAA GGAGGGGCTG GGAGAGGTGG TCCCCTTAGC 600
TCCCCCTCCC CAGCCAGAAC AGAATCACTG ACCCTGAGGC TTGGCCTGGG CTGCATCTGC 660
TTCCAGCAAC TTCCATGAAG GACGTGACTG TAGACGAGGC CCACTCCTTG CACGGCCAGG 720
GCCCTCAGGG TGCCCAGGGA AGTGAGGGCC AGTGCTGGAA GCTCCAGCCT AGCACTGGGC 780
ACCTCCCCGG TGAGTGGCTG TTGGGGGCAG AGCTGCCAGC AGGGAGAGGA CAGCTATGAA 840
AGACGTGGCT CCAGGCCTTG CACTGCCACC TGTCAACTCG GGGCTTTGGG CAGGCTGCTT 900
TTCTCCTTTG GGCCTCAGTT TCCTCATCTG TGTAGTGGAG ACCAACCACG GTACTTCGAA 960
GGTCTGTAGA AATTCCTGGT ACACAGCAAG TGCTTAATAA TGGTATGAGC TACTATTAGC 1020
TAGTGCCTGT 1030